November 28, 2001 |
Pregnant HIV-positive women have no inherent right to an anti-AIDS drug that could save their babies from the disease, lawyers for the South African government argued. Activists have sued the state in a bid to force it to make nevirapine available to expectant mothers with HIV. Studies show it can reduce virus transmission from mother to child during labor by as much as 50%. The government argues that the drug's safety is unproven.
December 20, 2001 |
The government announced Wednesday that it will challenge a court order to widen access to a key AIDS drug, saying the ruling may infringe on its constitutional right to determine policy. The Pretoria High Court ordered the government Friday to institute a comprehensive program to reduce mother-to-child transmission of HIV, the virus that causes AIDS, and make the drug nevirapine available to HIV-positive pregnant women.
June 25, 1996 |
The Food and Drug Administration approved the first in a new class of AIDS medicines Monday, clearing patients to start adding the drug nevirapine to their treatment combinations this summer. Nevirapine, to be sold under the brand name Viramune, targets the same element of the human immunodeficiency virus that many older medicines do, inhibiting an enzyme key to HIV's reproduction.